This was followed by clinical expression and survival analyses, which validated eight genes (IGFBP3, CD72, SERPINH1, CHRDL2, LRP11, SPARCL1, DBI and HYAL1) as significant CRC candidates. Here, HYAL1 is linked to colorectal carcinoma.